ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
January 2026
Latest News
Mirion announces appointments
Mirion Technologies has announced three senior leadership appointments designed to support its global nuclear and medical businesses while advancing a company-wide digital and AI strategy. The leadership changes come as Mirion seeks to advance innovation and maintain strong performance in nuclear energy, radiation safety, and medical applications.
Lawrence N. Oji, David T. Hobbs, Paul D. d'Entremont
Nuclear Technology | Volume 145 | Number 2 | February 2004 | Pages 204-214
Technical Paper | Reprocessing | doi.org/10.13182/NT04-A3470
Articles are hosted by Taylor and Francis Online.
Laboratory-scale results on experiments performed to examine the feasibility of isotopic dilution of 235U in supernatant liquid storage tanks at the Savannah River Site are described. The isotopic dilution tests were accomplished by adding an alkaline depleted uranium solution to small portions of simulated and actual storage tank waste solutions with enriched 235U compositions. Based on the laboratory observations, recommendations were made, which involved the addition of significant quantities of uranyl carbonate solution to more than 4 million l of 235U enriched waste stored in tank 43H at the site to reduce the risk for criticality.A post-uranyl carbonate addition analysis on the tank supernate confirmed the effectiveness of depleted uranium in isotopic dilution of 235U. The 235U enrichment in tank 43H was isotopicaly diluted from an original high of >4 wt% down to <0.5 wt%, as predicted from the laboratory investigations.